Relationship between HbA1c and Continuous Glucose Monitoring in Chinese Population: A Multicenter Study
暂无分享,去创建一个
Wenying Yang | Xin Gao | Jian Zhou | Yongde Peng | Qiang Li | Weiqing Wang | Weiqing Wang | Qiang Li | Xin Gao | Yongde Peng | Wenying Yang | Yanbing Li | Jian Zhou | Hong Li | X. Ran | X. Luan | Hong Li | Yun Xie | Yifei Mo | Xingwu Ran | Yanbing Li | Xiaojun Luan | Yun Xie | Weiping Jia | W. Jia | Y. Mo
[1] Jiang He,et al. Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.
[2] A. M. Kyaw,et al. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes , 2013, Diabetology & Metabolic Syndrome.
[3] D. Golicki,et al. Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials. , 2012, European journal of endocrinology.
[4] Elizabeth Selvin,et al. Racial Differences in Glycemic Markers: A Cross-sectional Analysis of Community-Based Data , 2011, Annals of Internal Medicine.
[5] V. Basevi. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[6] K. Xiang,et al. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey , 2010, BMJ : British Medical Journal.
[7] K. Dou,et al. Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.
[8] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[9] Weiqing Wang,et al. Reference Values for Continuous Glucose Monitoring in Chinese Subjects , 2009, Diabetes Care.
[10] V. Basevi. Standards of medical care in diabetes--2007. , 2009, Diabetes care.
[11] D. Schoenfeld,et al. Translating the A1C Assay Into Estimated Average Glucose Values , 2008, Diabetes Care.
[12] L. Thabane,et al. The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review. , 2008, Diabetes research and clinical practice.
[13] Darrell M. Wilson,et al. Relationship of A1C to Glucose Concentrations in Children With Type 1 Diabetes , 2008, Diabetes Care.
[14] A. Haliassos,et al. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[15] John M. Lachin,et al. Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program , 2007 .
[16] S. Grundy,et al. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus , 2006, Diabetes Care.
[17] S. Pocock,et al. Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes , 2006, Diabetes Care.
[18] N. Clark,et al. Standards of Medical Care in Diabetes: Response to Power , 2006 .
[19] John H Fuller,et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.
[20] F. Nuttall,et al. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. , 2004, Diabetes care.
[21] D. Goldstein,et al. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.
[22] T. Spector,et al. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. , 2001, Diabetes.
[23] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[24] B. Keevil,et al. Biological Variation of Glycated Hemoglobin: Implications for diabetes screening and monitoring , 1998, Diabetes Care.
[25] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[26] C. Jackson,et al. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia , 1990, Diabetologia.
[27] Chinese clinical guideline for continuous glucose monitoring (2012). , 2012, Chinese medical journal.
[28] [Clinical application guide of blood glucose monitoring in China (Edition 2011)]. , 2011, Zhonghua yi xue za zhi.